| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 620 | $83.16 | $51,557.96 | -0.5% | -29.5% | -56.7% | |
| Dec 2, 2021 | WAT Waters Corp /de/ | Conard Edward | Director | Sell | 4,000 | $336.01 | $1,344,040.00 | -5.3% | -5.5% | +4.0% | |
| Dec 2, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 4,184 | $12.92 | $54,057.28 | -2.3% | -25.0% | -78.5% | |
| Dec 2, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 32,732 | $211.42 | $6,920,359.04 | -0.3% | -28.0% | -1.1% | |
| Dec 2, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 32,732 | $211.42 | $6,920,359.04 | -0.3% | -28.0% | -1.1% | |
| Dec 1, 2021 | TMO Thermo Fisher Scientific Inc. | Stevenson Mark59 | Executive Vice President &COO | Sell | 26,925 | $631.88 | $17,013,310.34 | -3.3% | -13.2% | -9.6% | |
| Dec 1, 2021 | PRPO Precipio, Inc. | Sabet Ahmed Zaki47 | Chief Operating Officer | Buy | 258 | $1.89 | $487.62 | +5.1% | -18.6% | -58.5% | |
| Dec 1, 2021 | PRPO Precipio, Inc. | Danieli Ilan | Chief Executive Officer | Buy | 2,577 | $1.89 | $4,870.53 | +10.9% | -18.6% | -58.5% | |
| Dec 1, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 7,219 | $90.80 | $655,454.14 | -8.8% | -27.8% | -53.7% | |
| Nov 30, 2021 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 12,294 | $326.00 | $4,007,844.00 | -35.6% | -14.6% | -14.7% | |
| Nov 30, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 100,000 | $13.65 | $1,365,000.00 | -17.1% | -22.5% | -81.3% | |
| Nov 30, 2021 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 669 | $152.04 | $101,712.75 | -1.5% | -13.5% | +3.4% | |
| Nov 30, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 12,312 | $212.07 | $2,611,018.63 | -0.1% | -26.2% | +1.2% | |
| Nov 30, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 12,312 | $212.07 | $2,611,018.63 | -0.1% | -26.2% | +1.2% | |
| Nov 29, 2021 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 8,930 | $1,536.29 | $13,719,034.40 | -2.3% | -8.3% | -8.1% | |
| Nov 29, 2021 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | Chief Operating Officer | Sell | 636 | $95.42 | $60,685.91 | -0.2% | -35.8% | -63.7% | |
| Nov 29, 2021 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 37,513 | $327.00 | $12,266,751.00 | -54.8% | -15.9% | -20.4% | |
| Nov 29, 2021 | IQV Iqvia Holdings Inc. | Connaughton John | Director | Sell | 555,094 | $262.60 | $145,767,684.40 | -89.9% | -13.7% | -20.3% | |
| Nov 29, 2021 | DHR Danaher Corp /de/ | Zerhouni Elias A.50 | Director | Sell | 3,409 | $328.42 | $1,119,594.01 | -11.9% | -15.9% | -20.4% | |
| Nov 29, 2021 | WGS Genedx Holdings Corp. | Ro Isaac89 | Chief Financial Officer | Sell | 12,115 | $6.63 | $80,322.45 | -9.5% | -47.0% | -93.2% | |
| Nov 26, 2021 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 2,589 | $325.50 | $842,719.50 | -27.5% | -16.1% | -17.3% | |
| Nov 26, 2021 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 12,300 | $325.33 | $4,001,522.10 | -35.3% | -16.1% | -17.3% | |
| Nov 26, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 29,649 | $212.11 | $6,288,734.57 | -0.3% | -30.0% | +3.7% | |
| Nov 26, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 29,649 | $212.11 | $6,288,734.57 | -0.3% | -30.0% | +3.7% | |
| Nov 26, 2021 | NEO Neogenomics Inc | Brown Douglas Matthew79 | Chief Strategy Officer | Sell | 100,000 | $36.96 | $3,695,999.89 | -42.6% | -43.2% | -72.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.